ARQT
Arcutis Biotherapeutics Inc
26.30$
-0.4%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -64.5% | +266.5% | -37.7% | +45.0% | +59.4% | -7.7% | +23.8% | +21.7% | +30.5% | -18.6% | +23.2% | – | |
| – | +90.0% | +45.0% | +6.4% | +58.9% | +25.5% | +27.9% | -15.2% | +15.9% | +34.6% | -16.3% | +11.8% | – | |
| – | -69.5% | +310.6% | -40.9% | +43.3% | +64.2% | -11.5% | +29.8% | +22.3% | +30.1% | -18.8% | +24.4% | – | |
| – | -9.4% | -2.7% | -16.6% | +1.1% | -25.7% | +21.2% | +10.9% | +0.8% | +4.3% | +49.8% | -33.5% | – | |
| – | +186.7% | -59.8% | +6.2% | +1.1% | -2.1% | +11.1% | +8.1% | -9.8% | +26.6% | -6.2% | +10.9% | – | |
| – | -1.9% | +7.6% | -0.6% | +1.1% | -8.0% | +13.1% | +8.7% | -7.5% | +21.2% | +5.3% | -2.1% | – | |
| – | – | – | – | – | – | – | – | – | +115.7% | -149.4% | – | – | |
| – | +2.7% | -3.6% | +0.1% | -11.1% | -16.6% | -46.3% | +1.6% | +1.4% | -2.3% | +45.6% | -22.0% | – | |
| – | – | – | – | – | – | – | – | – | +138.5% | -162.7% | – | – | |
| – | -99.2% | +1,196.0% | +0.0% | – | – | -13.6% | +22.6% | -76.6% | +487.5% | -80.2% | +46.2% | – | |
| – | – | – | – | – | – | – | – | – | +134.8% | -164.9% | – | – | |
| – | – | – | – | – | – | – | – | – | +98.9% | -128.3% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.